| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 06/18/2002 | US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/14/2002 | WO2001044187A1 Novel substituted tricyclic compounds |
| 06/14/2002 | CA2394778A1 Novel substituted tricyclic compounds |
| 06/13/2002 | WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 06/13/2002 | WO2002046164A1 Therapeutic compounds |
| 06/13/2002 | WO2002046155A1 Synthesis of fused pyrrolecarboxamides |
| 06/13/2002 | WO2002046154A1 Peroxisome proliferator activated receptor d activators |
| 06/13/2002 | WO2002046153A2 Process for the preparation of zafirlukast |
| 06/13/2002 | WO2002046149A2 2-thio-5-amino substituted benzoquinones, their manufacture and their use in rubber |
| 06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
| 06/13/2002 | WO2002024648A3 Process for the preparation of cell proliferation inhibitors |
| 06/13/2002 | WO2002015891A3 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors |
| 06/13/2002 | WO2001037819A3 Use of indirubine derivatives for making medicines |
| 06/13/2002 | US20020072636 Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof |
| 06/13/2002 | US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 06/13/2002 | US20020072531 Useful as anticoagulants in mammals; inhibitors of factor Xa |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | CA2430841A1 Synthesis of fused pyrrolecarboxamides |
| 06/12/2002 | EP1212375A2 Ph sensitive cyanine dyes as reactive fluorescent reagents |
| 06/12/2002 | EP1212320A2 Phenylpiperazines as serotonin reuptake inhibitors |
| 06/12/2002 | EP1212318A1 Substituted indolinones as tyrosine kinase inhibitors |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212298A1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212268A1 Catalyst for pauson-khand reaction |
| 06/12/2002 | EP1212081A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 06/12/2002 | EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/12/2002 | EP0782577B1 Asymmetric ligands useful for transition metal catalyzed bond forming reactions and epoxide reactions therewith |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/11/2002 | US6403808 Treating mental disorders |
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403644 For prevention and/or treatment of diseases induced by overexpression and excess activity of matrix metalloproteinase; for example, rheumatoid, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis |
| 06/11/2002 | US6403632 Cyclic amide derivative |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403055 Carboxylated polyamine compound |
| 06/11/2002 | CA2065192C Process for the production of 2-azabicyclo[2.2.1]hept-5-en-3-one |
| 06/11/2002 | CA2031756C Isatine derivatives, their preparation and use |
| 06/06/2002 | WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044152A1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 06/06/2002 | WO2002044151A1 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers |
| 06/06/2002 | WO2002044150A1 Chemical process and new intermediates |
| 06/06/2002 | WO2002044149A1 Indole and dihydroindole derivatives |
| 06/06/2002 | WO2002044148A2 Aryl-substituted indirubin derivatives, the production thereof and use of the same |
| 06/06/2002 | WO2002044120A1 Compounds active at the glucocorticoid receptor iii |
| 06/06/2002 | WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 06/06/2002 | WO2002014294A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 06/06/2002 | WO2001003684A3 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/06/2002 | US20020068831 Intermediate for the synthesis of amlodipine, a process for the preparation there and corresponding use |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068692 Administration a melatonin blocker to patients with disorders associated with altered dopamine function; preclinical diagnosis by administering melatonin to induce a mild transient form of the disorder |
| 06/06/2002 | CA2430343A1 1,4-disubstituted piperazine derivatives useful as uro-selective .alpha.1-adrenoceptor blockers |
| 06/06/2002 | CA2430064A1 Chemical process and new intermediates |
| 06/06/2002 | CA2429816A1 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 06/05/2002 | EP1211301A1 Organic electroluminescent device |
| 06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/05/2002 | EP1210333A2 Novel herbicides |
| 06/05/2002 | EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
| 06/05/2002 | EP1210321A1 Aminosalicylclic acid amides and their use for combating organisms that are harmful to plants |
| 06/05/2002 | EP0966430B1 Anti-inflammatory compounds |
| 06/05/2002 | EP0934319B1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 06/05/2002 | EP0923551B1 4-aminoethoxy indolone derivatives |
| 06/05/2002 | EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399808 Reacting amine with carbon dioxide in anhydrous solvent |
| 06/04/2002 | US6399785 Multiply-substituted fullerenes |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399631 Carbazole neuropeptide Y5 antagonists |
| 06/04/2002 | US6399614 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |
| 05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
| 05/30/2002 | WO2002042412A2 Protease inhibitors and their pharmaceutical uses |
| 05/30/2002 | WO2002042304A2 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists |
| 05/30/2002 | WO2002042294A1 1-sulfonyl substituted tryptophane derivatives and its use as integrin inhibitors |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 05/30/2002 | WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders |
| 05/30/2002 | WO2002041835A2 Estrogen receptor modulators |
| 05/30/2002 | WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 05/30/2002 | WO2002014275A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 05/30/2002 | WO2001064646A3 Hydrazones and analogs as cholesterol lowering agents |
| 05/30/2002 | WO2001047882A3 Substance library which can be obtained by reacting aldehydes with secondary amines, acid chlorides and naphthol, pyrrole and/or indole compounds |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020065192 Productivity catalysts and microstructure control |
| 05/30/2002 | US20020064794 Modified carbocyanine dyes and their conjugates |
| 05/30/2002 | US20020064782 Fluorescent nucleotides |